Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs

Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum safe surgical resection and radio-chemotherapy, more than 95% of GBM patients die within 5 years after diagnosis. Thus, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumitru, Claudia A., Sandalcioglu, I. Erol, Karsak, Meliha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964193/
https://www.ncbi.nlm.nih.gov/pubmed/29867351
http://dx.doi.org/10.3389/fnmol.2018.00159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964193/
https://www.ncbi.nlm.nih.gov/pubmed/29867351
http://dx.doi.org/10.3389/fnmol.2018.00159

Ejemplares similares